share_log

ADRs End Lower; Onion Global, Wolters Kluwer Among Companies Actively Trading

ADRs End Lower; Onion Global, Wolters Kluwer Among Companies Actively Trading

美国存托凭证收盘走低;洋葱环球、沃尔特斯·克鲁沃等公司交易活跃
Dow Jones Newswires ·  2021/10/29 19:02
   By Kimberly Chin 
作者:金伯利·陈(Kimberly Chin)

International stocks trading in New York finished lower on Friday. The S&P/BNY Mellon index of American depositary receipts fell 1.3% to 164.33. The European index slipped 0.7% to 147.31. The Asian index declined 2% to 219.67. The Latin American index decreased 2.6% to 175.34. And the emerging-markets index tumbled 2.4% to 360.25.

周五,纽约国际股市收盘走低。S&P/纽约梅隆美国存托凭证指数跌1.3%,报164.33点。欧洲指数下滑0.7%,至147.31点。亚洲指数下跌2%,至219.67点。拉丁美洲指数下跌2.6%,至175.34。新兴市场指数暴跌2.4%,至360.25点。

Onion Global Ltd.'s ADRs declined 38% after the company said it agreed with certain institutional and accredited investors to raise $25 million in a private placement.

洋葱环球有限公司(Onion Global Ltd.)的美国存托凭证(ADR)下跌38%,此前该公司表示,已与某些机构和认可投资者达成一致,将通过私募募集2,500万美元。

ADRs of Wolters Kluwer NV, which trade over the counter, tumbled 1.7% after the company said Friday that it has acquired LicenseLogix LLC, a provider of U.S. business licensing services. The Netherlands-based information, software and services company said the deal is expected to have an immaterial impact on its adjusted earnings for the first full year.

在场外交易的Wolters Kluwer NV的ADR暴跌1.7%,此前该公司周五表示,已收购美国商业许可服务提供商LicenseLogix LLC。这家总部位于荷兰的信息、软件和服务公司表示,预计这笔交易将对其第一个全年的调整后收益产生无形的影响。

Banco Bilbao Vizcaya Argentaria SA's ADRs rose 5.8% after the Spanish bank reported a rise in third-quarter profit and said it received the go-ahead to launch a buyback program.

西班牙毕尔巴鄂比兹卡亚银行(Banco Bilbao Vizcaya)的美国存托凭证(ADR)上涨5.8%,此前这家西班牙银行公布第三季度利润上升,并表示已获得启动回购计划的许可。

Novo Nordisk AS's ADRs rose 2.3% Friday after the Danish pharmaceutical company raised its full-year sales and operating profit guidance to reflect higher-than-expected market share gains in its Ozempic glucagon-like peptide-1 drug (GLP-1) for treating type 2 diabetes, GLP-1 market growth and obesity-care sales, mainly in the U.S.

诺和诺德(Novo Nordisk)股价上周五上涨2.3%,此前这家丹麦制药公司上调了全年销售和营业利润指引,以反映其治疗2型糖尿病的Ozempic胰高血糖素样肽-1(GLP-1)的市场份额增长高于预期,GLP-1的市场增长以及主要在美国的肥胖护理销售。

Write to Kimberly Chin at kimberly.chin@wsj.com

写信给Kimberly Chin,电子邮件:kimberly.chin@wsj.com

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发